BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 6475499)

  • 1. Systemic amyloid myopathy--light-microscopic and fine-structural study of the skeletal muscles with histochemical and immunohistochemical study of amyloid.
    Ii K; Hizawa K; Nunomura S; Morizumi H
    Acta Neuropathol; 1984; 64(2):114-21. PubMed ID: 6475499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amyloid myopathy: clinicopathologic study of 16 cases.
    Prayson RA
    Hum Pathol; 1998 May; 29(5):463-8. PubMed ID: 9596269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bence-Jones protein-type myeloma with amyloid myopathy presenting as amyloidomas and extensive amyloid deposits in the muscularis propria: a rapidly fatal autopsy case.
    Ikezawa Y; Oka K; Nagayama R; Okubo Y; Yonekawa N; Hirai F; Ebihara I; Mori N
    Int J Surg Pathol; 2012 Feb; 20(1):83-8. PubMed ID: 21632635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myopathy associated with amyloid angiopathy.
    Bruni J; Bilbao JM; Pritzker PH
    Can J Neurol Sci; 1977 Feb; 4(1):77-80. PubMed ID: 837267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skeletal muscle amyloid deposition in AL- (primary or myeloma-associated), AA- (secondary), and prealbumin-type amyloidosis.
    Yamada M; Tsukagoshi H; Hatakeyama S
    J Neurol Sci; 1988 Jun; 85(2):223-32. PubMed ID: 3385435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amyloid myopathy presenting with distal atrophic weakness.
    Smestad C; Monstad P; Lindboe CF; Mygland A
    Muscle Nerve; 2004 Apr; 29(4):605-9. PubMed ID: 15052628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Motor impairment in amyloid-associated muscle pseudohypertrophy].
    Komiyama A; Kijima M; Takahashi M; Ono Y; Hirayama K
    Rinsho Shinkeigaku; 1991 Mar; 31(3):296-300. PubMed ID: 1893669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Axial myopathy due to primary amyloidosis.
    Friedman Y; Paul JT; Turley J; Hazrati LN; Munoz D
    Muscle Nerve; 2007 Oct; 36(4):542-6. PubMed ID: 17405139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A case of amyloid myopathy diagnosed during the treatment of myopathy associated with anti-signal recognition particle antibodies].
    Kawakami N; Katsuyama Y; Hagiwara Y; Yoshida H; Kim K; Harada K
    Rinsho Shinkeigaku; 2017 Apr; 57(4):168-173. PubMed ID: 28367947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early sarcolemmal dysfunction in skeletal muscle amyloidosis.
    Doriguzzi C; Mongini T; Troni W; Monga G
    J Neurol; 1987 Jan; 234(1):52-4. PubMed ID: 3819787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amyloid myopathy: characteristic features of a still underdiagnosed disease.
    Chapin JE; Kornfeld M; Harris A
    Muscle Nerve; 2005 Feb; 31(2):266-72. PubMed ID: 15478123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myopathy in a patient with systemic AA amyloidosis possibly induced by psoriasis vulgaris: An autopsy case.
    Tanabe H; Maki Y; Urabe S; Higuchi I; Obayashi K; Hokezu Y
    Muscle Nerve; 2015 Dec; 52(6):1113-7. PubMed ID: 26179325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amyloidosis causing a progressive myopathy.
    Nadkarni N; Freimer M; Mendell JR
    Muscle Nerve; 1995 Sep; 18(9):1016-8. PubMed ID: 7643863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of isolated amyloid myopathy.
    Liewluck T; Milone M
    Eur J Neurol; 2017 Dec; 24(12):1437-1445. PubMed ID: 28888072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Case of amyloidosis with amyloid deposition detected only in skeletal muscles].
    Ohtsuka Y; Yasui N; Sekiguchi K; Kowa H; Nishino I; Kanda F; Toda T
    Rinsho Shinkeigaku; 2012; 52(10):739-43. PubMed ID: 23064623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case of systemic AL amyloidosis diagnosed on muscle biopsy].
    Yata T; Miwa T; Araki K; Kida T; Toyooka K; Nishino I; Tatsumi C
    Rinsho Shinkeigaku; 2020 Jan; 60(1):60-63. PubMed ID: 31852873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Non hypertrophic amyloid myopathy with muscular inflammation in plasma cell dyscrasia].
    Pouget J; Pellissier JF; Azulay JP; Vallat JM; Visy JM; Serratrice G
    Rev Neurol (Paris); 1992; 148(3):200-6. PubMed ID: 1604134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pseudo-hypertrophic pelvi-crural amyloid myopathy in lambda light-chain myeloma. Clinical, morphological and immunocytochemical study].
    Pellissier JF; Aquilina C; Murisasco A; Toga M
    Rev Neurol (Paris); 1987; 143(2):128-36. PubMed ID: 3110902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proximal weakness of the extremities as main feature of amyloid myopathy.
    Jennekens FG; Wokke JH
    J Neurol Neurosurg Psychiatry; 1987 Oct; 50(10):1353-8. PubMed ID: 3681315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic amyloidosis terminating in cardiac insufficiency.
    Ishimura E; Shoji S; Fujimoto T
    Acta Pathol Jpn; 1986 Oct; 36(10):1593-604. PubMed ID: 3799192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.